Trial Profile
Randomized Phase II Trial of the Sequences of Anthracyline and Taxane in Locally Advanced Breast Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2022
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
- Indications Advanced breast cancer; Early breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- Acronyms NeoSAMBA
- 12 Feb 2020 Planned End Date changed from 1 Dec 2019 to 1 Jun 2020.
- 12 Feb 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Apr 2020.
- 14 Aug 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.